Balyasny Asset Management’s Abivax ABVX Stock Holding History
Bought
Maintained
Sold
Other funds holding ABVX
TCM
HI
DGM
VPC
JT
ACM
CP
Balyasny Asset Management's ABVX Position: Q2 2026 in Review
Balyasny Asset Management increased its Abivax (ABVX) stake by 183% in Q2 2026, buying an estimated $44.2M and bringing the position to 603,840 shares worth $80.5M. The position accounts for 0.1% of the portfolio, ranked #234.
Balyasny Asset Management first reported a position in ABVX in Q3 2025 and has held it in 4 quarters since. 303 funds tracked by Wall St. Rank hold ABVX as of Q2 2026.
- Balyasny Asset Management held 603,840 shares of Abivax worth $80.5M as of Q2 2026.
- Balyasny Asset Management bought 390,151 Abivax shares in Q2 2026, an estimated $44.2M.
- Abivax made up 0.1% of Balyasny Asset Management's portfolio in Q2 2026, its #234 holding.
- Balyasny Asset Management first reported a position in Abivax in Q3 2025 and has held it in 4 quarters since.
- 303 funds tracked by Wall St. Rank held Abivax as of Q2 2026.
Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.